deltatrials
Terminated PHASE2 INTERVENTIONAL 3-arm NCT01801917

Efficacy and Tolerability of BAF312 in Patients With Polymyositis

A Multi-centre Double-blind, Placebo Controlled, Proof of Concept Study to Evaluate the Efficacy and Tolerability of BAF312 in Patients With Polymyositis

Sponsor: Novartis Pharmaceuticals

Conditions Polymyositis
Interventions BAF312 Placebo
Updated 10 times since 2017 Last updated: Dec 9, 2020 Started: Apr 24, 2013 Primary completion: Aug 5, 2016 Completion: Aug 5, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Novartis Pharmaceuticals

See all terminations from Novartis Pharmaceuticals

This PHASE2 trial investigates Polymyositis and is currently terminated or withdrawn. Novartis Pharmaceuticals leads this study, which shows 10 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~May 2017 · 3 months · monthly snapshotCompleted~May 2017 – ~Jan 2018 · 8 months · monthly snapshotTerminated~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotTerminated~Feb 2021 – ~Jul 2024 · 41 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  4. Feb 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  5. Jan 2021 — Feb 2021 [monthly]

    Terminated PHASE2

▶ Show 5 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  2. Jan 2018 — Jun 2018 [monthly]

    Terminated PHASE2

  3. May 2017 — Jan 2018 [monthly]

    Terminated PHASE2

    Status: Completed → Terminated

  4. Feb 2017 — May 2017 [monthly]

    Completed PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Novartis Pharmaceuticals
Data source: Novartis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations